Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SST-6007 in Female Sexual Arousal Disorder
NCT02570282Phase 2Completed
- Sponsor
- Strategic Science & Technologies
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in Sexual Arousal Disorder, sponsored by Strategic Science & Technologies. Started Sep 2015; status: completed.
02
Drugs
sildenafil
03
Conditions
Sexual Arousal Disorder
Beyond the preview
Go deeper on NCT02570282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570282.